Mebrofenin
Active ingredient
Sold as CHOLEDIAM
- Drug class
- -
- Availability
- Prescription only
- Routes
- Intravenous
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 5
Overview
Mebrofenin is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | August 28, 2024 |
| GB United Kingdom | MHRA | 1 | March 18, 2022 |
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
After reconstitution with sodium pertechnetate [99mTc] injection : - Hepatobiliary imaging. - Hepatobiliary function studies.
How to take
Drug interactions
Known interactions involving Mebrofenin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 11492bd5-2ade-4e… · revised August 28, 2024 [PDF]
- [2]MHRA (UK) · PL228790001 · revised March 18, 2022
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.